Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevention and Prophylaxis (Thromboprophylaxis - ACT) of Cancer Associated Thrombosis (CAT) in High Risk Oncology Patients: ACT4CAT.

NCT03909399 is registered in ClinicalTrials.gov with Hellenic Society of Medical Oncology as lead sponsor.

NCT NCT03909399
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03909399 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevention and Prophylaxis (Thromboprophylaxis - ACT) of Cancer Associated Thrombosis (CAT) in High Risk Oncology Patients: ACT4CAT.
Lead sponsor
Hellenic Society of Medical Oncology
Phase
Observational
Overall status
Unknown status
Start date
January 25, 2019
Completion date
March 31, 2021
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

deep vein thrombosis, iliac; thrombosis, pulmonary embolism, vena cava thrombosis